AstraZeneca Pharmaceuticals LP et al v. Fresenius Kabi USA, LLC > Summary
Court Case Number 1:17-cv-01795
Filing Date Dec 14, 2017
Termination Date Jan 22, 2018
Court Delaware District Court
Status Dismissed - Settled
JudgesVacant Judgeship, Mary Pat Thynge
Plaintiff
Defendant
Plaintiff Attorneys
7AstraZeneca
Attorney Name: Lisa B. Pensabene
O'Melveny & Myers LLP
AstraZeneca
Attorney Name: Benjamin A. Smyth
McCarter & English
AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English
AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
AstraZeneca
Attorney Name: Filko Prugo
O'Melveny & Myers LLP
AstraZeneca
Attorney Name: Caitlin P. Hogan
O'Melveny & Myers LLP
AstraZeneca
Attorney Name: Eberle Schultz
O'Melveny & Myers LLP
Defendant Attorneys
5Fresenius Kabi USA
Attorney Name: Imron T. Aly
ArentFox Schiff
Fresenius Kabi USA
Attorney Name: David A. Bilson
Phillips, McLaughlin & Hall, P.A.
Fresenius Kabi USA
Attorney Name: Megan C. Haney
Phillips, McLaughlin & Hall, P.A.
Fresenius Kabi USA
Attorney Name: John C. Phillips, Jr.
Phillips, McLaughlin & Hall, P.A.
Attorney Name: Christine W. Feller
Counter Defendant
4AstraZeneca
Attorney Name: Lisa B. Pensabene
O'Melveny & Myers LLP
AstraZeneca
Attorney Name: Benjamin A. Smyth
McCarter & English
AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English
AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
08466139 | Formulation | Jun 18, 2013 |
08329680 | Formulation | Dec 11, 2012 |
07456160 | Formulation | Nov 25, 2008 |
06774122 | Formulation | Aug 10, 2004 |